Adenovirus type 4 a

Ended Awarded Last action

Contract number
SPE2DP26F5468
Awardee
Awarding agency
Obligated
$343,526

Award facts

Contract value 100% obligated
$343,526.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Defense Medical Supply Chain issued a $343,526.40 delivery order to Teva Pharmaceuticals Usa, Inc. on May 11, 2026, for Adenovirus Type 4 vaccine, with an ultimate completion date of May 19, 2026.

The order is firm fixed price with no set-aside. Place of performance is Parsippany, New Jersey. The source does not identify an explicit parent vehicle name; the order references Teva's ongoing role as a national prime vendor for Adenovirus Type 4 vaccine delivery to Defense Logistics Agency Troop Support Medical, under which Teva has executed 559 prior delivery orders totaling $665.9 million in combined potential value.

Quick answers

Who was awarded contract SPE2DP26F5468?

SPE2DP26F5468 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on May 11, 2026.

How much is contract SPE2DP26F5468 worth?

The government has obligated $343,526 on SPE2DP26F5468.

Is contract SPE2DP26F5468 an order under another contract?

Yes. SPE2DP26F5468 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP26F5468 competed?

The extent of competition for SPE2DP26F5468 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login